KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jun 23, 2026 - 3:59PM >>  ABB India 7153.6  [ -1.39% ]  ACC 1331.45  [ -1.29% ]  Ambuja Cements 415  [ -3.00% ]  Asian Paints 2660.7  [ -0.52% ]  Axis Bank 1362.55  [ 0.28% ]  Bajaj Auto 10015.45  [ -1.79% ]  Bank of Baroda 277.7  [ -2.94% ]  Bharti Airtel 1901.1  [ -0.83% ]  Bharat Heavy 399.7  [ -2.90% ]  Bharat Petroleum 308.5  [ 0.00% ]  Britannia Industries 5243.85  [ 0.55% ]  Cipla 1435  [ 1.39% ]  Coal India 443.9  [ -1.11% ]  Colgate Palm 1980.5  [ -0.07% ]  Dabur India 419.9  [ -0.58% ]  DLF 610.3  [ -2.69% ]  Dr. Reddy's Lab. 1300.4  [ 0.72% ]  GAIL (India) 173.75  [ -2.00% ]  Grasim Industries 3141.45  [ -1.09% ]  HCL Technologies 1109.9  [ -1.79% ]  HDFC Bank 774.5  [ -1.48% ]  Hero MotoCorp 4980  [ -0.10% ]  Hindustan Unilever 2164.5  [ -0.94% ]  Hindalco Industries 987.5  [ -2.66% ]  ICICI Bank 1338.05  [ -1.01% ]  Indian Hotels Co. 725.05  [ -1.05% ]  IndusInd Bank 905.05  [ -1.94% ]  Infosys 1029.55  [ -3.36% ]  ITC 289.9  [ -0.45% ]  Jindal Steel 1082.35  [ -4.38% ]  Kotak Mahindra Bank 401.25  [ -0.24% ]  L&T 4176.5  [ -0.57% ]  Lupin 2356.55  [ 0.73% ]  Mahi. & Mahi 3038.35  [ -1.01% ]  Maruti Suzuki India 13422.2  [ 0.07% ]  MTNL 31.02  [ -3.06% ]  Nestle India 1392.25  [ -0.69% ]  NIIT 101  [ -2.69% ]  NMDC 85.2  [ -3.39% ]  NTPC 363.05  [ -1.06% ]  ONGC 244.45  [ -0.41% ]  Punj. NationlBak 107.35  [ -2.14% ]  Power Grid Corpn. 292.25  [ 0.83% ]  Reliance Industries 1309.3  [ -1.30% ]  SBI 1024  [ -1.63% ]  Vedanta 281.9  [ -7.85% ]  Shipping Corpn. 320.2  [ -0.84% ]  Sun Pharmaceutical 1867.8  [ 0.23% ]  Tata Chemicals 730.2  [ -0.42% ]  Tata Consumer 1103.65  [ -0.90% ]  Tata Motors Passenge 354.6  [ -1.90% ]  Tata Steel 193.65  [ -2.66% ]  Tata Power Co. 398.3  [ -1.86% ]  Tata Consult. Serv. 2060.15  [ -3.16% ]  Tech Mahindra 1416.25  [ -1.31% ]  UltraTech Cement 11338.1  [ -0.55% ]  United Spirits 1337.3  [ -0.37% ]  Wipro 174.5  [ -3.11% ]  Zee Entertainment 114.83  [ -0.82% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

VAIDYA SANE AYURVED LABORATORIES LTD.

23 June 2026 | 03:43

Industry >> Medical Equipment & Accessories

Select Another Company

ISIN No INE0JR301013 BSE Code / NSE Code / Book Value (Rs.) 68.17 Face Value 10.00
Bookclosure 30/09/2024 52Week High 335 EPS 8.55 P/E 20.01
Market Cap. 179.78 Cr. 52Week Low 144 P/BV / Div Yield (%) 2.51 / 0.00 Market Lot 400.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.

Company was originally incorporated as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Pune dated April 6, 1999 with the name `Vaidya Sane Ayurved Laboratories Private Limited'. Subsequently, our Company was converted into to a public limited company and the name of our Company was changed to `Vaidya Sane Ayurved Laboratories Limited' by a special resolution passed on November 19, 2021. A fresh Certificate of Incorporation consequent upon conversion was issued on November 25, 2021 by the Registrar of Companies, Pune.


Major Events and Milestones

2006
First Cardiac Prevention and Rehabilitation Hospital at Khopoli and opening of first Madhavbaug Clinic at
Dombivili, Maharashtra

2009
Setting up of inhouse research and development team at Thane.

2012
First Cardiac Prevention and Rehabilitation Hospital at Nagpur.

2013
Opening of 100th Madhavbaug Clinic at Kankavli, Ratnagiri

2014
Arogyam Hriday Sampada launched with a Mission to create awareness of heart disease.

2015
Launch of therapies for risk factors such as Diabetes, Obesity and Hypertension at Madhavbaug Clinics.

2016
Disease wise diet kits introduced at Madhavbaug Clinics.
Madhavbaug Institute of Preventive Cardiology established with MUHS.

2017
Entered into the state of Madhya Pradesh
Madhavbaug Clinics received Frost and Sullivan's 2017 India Best Practices Award.
Randomised controlled trial by Madhavbaug published in Indian Heart Journal, Official publication of Cardiological Society of India.

2018
Madhavbaug Clinics enters in India Book of Records for Conducting GTT of 661 diabetic patients in single day at 13 different locations.
Participated as main sponsor of World Ayurved Congress 2018 held at Ahmedabad.
Opening of 200th Madhavbaug Clinic at Nanded, Maharashtra
Entered into the state of Uttar Pradesh and Gujarat

2019
Entered into the state of Delhi
Madhavbaug introduced research based heart blockage management program.
Achieved new registrations of over 90,000 patients and more than 27,000 stress tests conducted and over 3,00,000 panchkarma procedures performed.

2020
Launch of MIB Pulse Mobile Application for patient engagement.
Entered into the state of Karnataka

2021
MIB Pulse Mobile Application achieved over 1,00,000 downloads
Opening of 250th Madhavbaug Clinic at Vashi.
Entered into the state of Chhattisgarh
Research trial on one year follow-up of Diabetes patients treated by Madhavbaug published in Journal of Association of Physicians of India.

2023 -Completed Acquisition of Dynamic Remedies Private Limited and UV Ayurgen Pharma Private Limited.

2024

-Company Announce that 'Acceptance of Research Paper in ""Asian Journal of Cardiology Research"

-Company Announces that "First Production Batch at UV Ayurgen Plant, Wholly Owned Subsidiary of Madhavbaug, takes a shape towards Completion".